ストックスクリーナーアプリを入手
2.47
2.37%
-0.06
アフターアワーズ：
2.50
0.03
+1.21%
前日終値:
$2.53
開ける：
$2.58
24時間の取引高:
3.51M
Relative Volume:
0.91
時価総額：
$383.14M
収益：
-
当期純損益:
$-110.78M
株価収益率:
-2.3084
EPS:
-1.07
ネットキャッシュフロー:
$-75.59M
1週間 パフォーマンス:
+7.39%
1か月 パフォーマンス:
+16.51%
6か月 パフォーマンス:
-46.54%
1年 パフォーマンス:
-68.89%
1日の値動き範囲:
$2.45
$2.65
1週間の範囲:
$2.28
$2.82
52週間の値動き範囲:
$1.15
$9.79
Humacyte Inc Stock (HUMA) Company Profile
名前
Humacyte Inc
セクター
電話
919-313-9633
住所
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
2.47 | 392.45M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-14 | 再開されました | H.C. Wainwright | Buy |
| 2024-12-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-12-11 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-14 | アップグレード | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-05-16 | ダウングレード | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 開始されました | Cowen | Outperform |
| 2021-09-24 | 開始されました | Oppenheimer | Outperform |
| 2021-09-22 | 開始されました | BTIG Research | Buy |
| 2021-09-16 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Humacyte Inc (HUMA) 最新ニュース
What makes Humacyte Inc. stock price move sharplyTriple-digit returns - jammulinksnews.com
Does Humacyte Inc. Equity Warrant stock perform well during market downturnsMaximize portfolio returns with smart trading - jammulinksnews.com
What institutional investors are buying Humacyte Inc. Equity Warrant stockAchieve fast wealth growth with smart picks - jammulinksnews.com
When is Humacyte Inc. stock expected to show significant growthAchieve rapid capital gains with smart investing - jammulinksnews.com
How does Humacyte Inc. compare to its industry peersSuperior trading gains - jammulinksnews.com
When is Humacyte Inc. Equity Warrant stock expected to show significant growthSkyrocketing investment returns - jammulinksnews.com
What catalysts could drive Humacyte Inc. Equity Warrant stock higher in 2025Unmatched profit potential - jammulinksnews.com
What are Humacyte Inc. company’s key revenue driversInvest confidently with professional market insights - jammulinksnews.com
How does Humacyte Inc. generate profit in a changing economyUnlock exclusive stock market insights - jammulinksnews.com
What institutional investors are buying Humacyte Inc. stockCapitalize on market momentum for maximum profit - jammulinksnews.com
How strong is Humacyte Inc. Equity Warrant company’s balance sheetMassive wealth growth - jammulinksnews.com
Should I hold or sell Humacyte Inc. stock in 2025Capitalize on fast-growing investment opportunities - jammulinksnews.com
Is Humacyte Inc. a growth stock or a value stockDiscover dynamic stocks ready to soar - jammulinksnews.com
Why is Humacyte Inc. Equity Warrant stock attracting strong analyst attentionMaximize your gains with expert trading tips - jammulinksnews.com
Is Humacyte Inc. stock overvalued or undervaluedMaximize your gains with professional insights - jammulinksnews.com
Humacyte Inc. Stock Analysis and ForecastExplosive trading opportunities - PrintWeekIndia
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
What drives Humacyte Inc. stock priceExceptional return forecasts - PrintWeekIndia
Humacyte Inc. Equity Warrant Stock Analysis and ForecastDynamic profit expansion - PrintWeekIndia
What analysts say about Humacyte Inc. Equity Warrant stockOutstanding investment returns - PrintWeekIndia
Will Humacyte Inc. Equity Warrant stock benefit from AI tech trendsBreakout stock performance - jammulinksnews.com
What analysts say about Humacyte Inc. stockExceptional risk-adjusted gains - PrintWeekIndia
Humacyte, Inc. (HUMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Humacyte rises on Symvess sale to military treatment facility - MSN
Would Humacyte (NASDAQ:HUMA) Be Better Off With Less Debt? - 富途牛牛
Humacyte stock rises after first Symvess sale to US Military facility By Investing.com - Investing.com South Africa
What drives Humacyte Inc. Equity Warrant stock priceExplosive trading opportunities - Autocar Professional
Humacyte, Inc. shares rise 1.47% after-hours after announcing first Symvess sale to U.S. Military Treatment Facility. - AInvest
Humacyte shares climb 6% after first Symvess sale to U.S. military hospital - MSN
Is Humacyte Inc. Equity Warrant a good long term investmentUnprecedented profit potential - Autocar Professional
Humacyte stock rises after first Symvess sale to US Military facility - Investing.com India
Humacyte Announces First Symvess™ Sale to Military Treatment Facility - The Manila Times
Humacyte Breaks Into Military Healthcare: FDA-Approved Symvess Now Serving 200,000 Military Personnel - Stock Titan
Humacyte Inc (HUMA) 財務データ
収益
当期純利益
現金流量
EPS
1.32%
1.06%
大文字化:
|
ボリューム (24 時間):